Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE METABOLIC FATE OF DIPHENYLHYDANTOIN IN THE DOG, RAT AND MAN

E. W. Maynert
Journal of Pharmacology and Experimental Therapeutics November 1960, 130 (3) 275-284;
E. W. Maynert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The metabolic fate of 5,5-diphenylhydantoin labeled in the 1-position with N15 was studied in rats and dogs. After intravenous administration of the drug to either species, more than 48 hours were required for the excretion of the isotope. A dog eliminated 80% of the intravenous dose of N15 in the urine, whereas rats excreted about 60% in the urine and 20% in the feces. Isotope dilution experiments revealed that rats eliminated 2% of an intravenous dose and 12% of an oral dose of diphenylhydantoin in the feces as unchanged drug.

Only small amounts of N15 from the drug appeared in the ammonia and urea fractions of the urine of dogs. Furthermore, isotope dilution experiments with diphenylhydantoin, diphenylhydantoic acid and α-aminodiphenylacetic acid revealed that these compounds appear in urine only in traces. These findings are incompatible with the view advanced by others that diphenylhydantoin is primarily degraded by hydrolysis and that most of the drug is completely destroyed in the body.

Various experiments indicated that dogs excreted 30 to 50% of a dose of diphenylhydantoin as glucuronic acid conjugates. Most of this urinary fraction could be accounted for by the glucuronide of 5-(p-hydroxyphenyl)-5-phenythydantoin (HPPH).

A paper-chromatographic method was used to determine free HPPH, β-glucuronidase-released HPPH and acid-released HPPH in the urine of man, dog and the rat. In man and the dog less than 1% of the dose of diphenylhydantoin was excreted as free HPPH; however, rats excreted 2 to 4% of the dose as this compound. Acid-released HPPH accounted for 50% of the dose in man and the dog but only 20 to 25% in the rat. In the urine of all 3 species β-glucuronidase liberated about 75% as much HPPH as was released by acid. No HPPH was freed by phenol sulfatase.

A number of experiments illustrated difficulties which can arise in a study of the metabolic fate of a drug which is very insoluble in water. The slow rate of excretion of metabolites after the intraperitoneal injection of diphenylhydantoin was found to be the result of crystallization of the drug within the peritoneal cavity. After oral administration the isotopic drug was absorbed very poorly compared with commercial preparations of diphenylhydantoin; this was explained by the larger size of the crystals in the isotopic preparation.

Footnotes

    • Received February 15, 1960.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 130, Issue 3
1 Nov 1960
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE METABOLIC FATE OF DIPHENYLHYDANTOIN IN THE DOG, RAT AND MAN
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE METABOLIC FATE OF DIPHENYLHYDANTOIN IN THE DOG, RAT AND MAN

E. W. Maynert
Journal of Pharmacology and Experimental Therapeutics November 1, 1960, 130 (3) 275-284;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

THE METABOLIC FATE OF DIPHENYLHYDANTOIN IN THE DOG, RAT AND MAN

E. W. Maynert
Journal of Pharmacology and Experimental Therapeutics November 1, 1960, 130 (3) 275-284;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Is Hydroxylamine-Induced Cytotoxicity a Valid Marker for Hypersensitivity Reactions to Sulfamethoxazole in Human Immunodeficiency Virus-Infected Individuals?
  • Powerful Activation of Skeletal Muscle Actomyosin ATPase by Goniodomin A Is Highly Sensitive to Troponin/Tropomyosin Complex
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics